ValueWalk’s November 2022 Hedge Fund Newsletter: Millennium Management Concludes Long-term Shift

Is This NYSE American Biopharma (ATNM) Ready To Burst Onto The Scene? Biotech stocks can start as little known afterthoughts and turn into explosive disruptors on the cusp of revolutionizing medicine in months, weeks, or even days. That's why we put together this comprehensive research report on Actinium Pharmaceuticals. See Full Report here >>> ValueWalk's November 2022 Hedge Fund Newsletter: Millennium Management Concludes Long-term Shift Welcome to our latest issue of ValueWalk's hedge fund update. Below subscribers can find an excerpt in text and the full issue in PDF format. Please send us your feedback! Featuring Millennium Management concludes long-term shift, hedge funds see huge outflows, and hedge funds offer downside protection. Q3 2022 hedge fund letters, conferences and more Read More 3 Roughed-Up Dividend Aristocrats with Good Long-Term Prospects Cash dividends help buffer market downturns and provide income that can be reinvested in cheaper shares. Sherwin-Williams' price increase and cost reduction moves mean that it should see better quarterly performances. Ecolab's products are in constant demand even during times of economic weakness. S&P Global Inc. is a large cap Aristocrat that has increased its […] Read More Be Sure You Own United Parcel Service for the Right Reasons United Parcel Service (UPS) looks fairly priced after earnings. The shipping company was a pandemic winner, but growth is regressing to historical averages. If you want to own UPS stock you should look at it for value, not growth. Some earnings reports are more significant than others. And that's the sense that you got when […] Read More Strong Fundamentals Make Bristol-Myers Squibb Stock A Real Value Bristol-Myers Squibb (NYSE:BMY) posted a modest gain after a double beat on earnings. The company continues to display strong fundamentals and a robust pipeline. Although growth investors may not be pleased, Bristol-Myers Squibb stock remains a strong value stock. Bristol-Myers Squibb Co (NYSE:BMY) posted a small gain after an earnings report; the company beat its […] Read More Local Bounti Rises As Insider Charles Schwab Backs PIPE Offering With Significant Equity Privacy Policy | Advertiser Disclosure Discusses terms of the equity offering, insiders who participated and some additional analysis Advanced local indoor produce grower Local Bounti's (NYSE:LOCL) shares marched higher on Wednesday rising 17.09% as the release of several Form 4's to the SEC for the stock sparked a flurry of buying activity. Q3 2022 hedge fund letters, conferences and more […] Read More Mortgage Rates Top 7%; Homeowners Respond To Climate Change; What Luxury Property Buyers Want On The Mortgage Front Freddie Mac (OTCMKTS:FMCC) reported the 30-year fixed-rate mortgage averaged 7.08% as of Oct. 27, up from last week when it averaged 6.94%. The 15-year fixed-rate mortgage averaged 6.36% up from last week when it averaged 6.23%. And the 5-year Treasury-indexed hybrid adjustable-rate mortgage averaged 5.96%, up from last week when it […] Read More Unsubscribe | Update your profile | 347 Fifth Avenue Suite 1402-390 , New York, NY 10016